Sumitomo Pharma Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 2.23% vs -6.03% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 364.02% vs -95.48% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "108,002.00",
          "val2": "105,649.00",
          "chgp": "2.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "25,261.00",
          "val2": "9,094.00",
          "chgp": "177.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9,053.00",
          "val2": "7,451.00",
          "chgp": "21.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "11,206.00",
          "val2": "2,415.00",
          "chgp": "364.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "185.70%",
          "val2": "31.10%",
          "chgp": "15.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 26.79% vs -43.38% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 107.50% vs -225.63% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "398,832.00",
          "val2": "314,558.00",
          "chgp": "26.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "47,984.00",
          "val2": "36,290.00",
          "chgp": "32.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8,558.00",
          "val2": "4,277.00",
          "chgp": "100.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7,497.00",
          "val2": "-352,719.00",
          "chgp": "97.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "23,635.00",
          "val2": "-314,929.00",
          "chgp": "107.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "56.20%",
          "val2": "-4.70%",
          "chgp": "6.09%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

108,002.00

105,649.00

2.23%

Operating Profit (PBDIT) excl Other Income

25,261.00

9,094.00

177.78%

Interest

9,053.00

7,451.00

21.50%

Exceptional Items

0.00

0.00

Consolidate Net Profit

11,206.00

2,415.00

364.02%

Operating Profit Margin (Excl OI)

185.70%

31.10%

15.46%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 2.23% vs -6.03% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 364.02% vs -95.48% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

398,832.00

314,558.00

26.79%

Operating Profit (PBDIT) excl Other Income

47,984.00

36,290.00

32.22%

Interest

8,558.00

4,277.00

100.09%

Exceptional Items

-7,497.00

-352,719.00

97.87%

Consolidate Net Profit

23,635.00

-314,929.00

107.50%

Operating Profit Margin (Excl OI)

56.20%

-4.70%

6.09%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 26.79% vs -43.38% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 107.50% vs -225.63% in Mar 2024

All Annual Results